O31 Value for money: a biologic pharmacist clinic

Value for Money

Discharge reductions--value for money?

Through the Nuclear Liabilities Management Authority White Paper, the UK Government and the Regulators have signalled a commitment to further improving the operation of the regulatory regime and to its operating within the principles of proportionality, transparency, consistency and accountability which underpin the Government's approach to regulation in general. Particular emphasis is placed u...

The Money Value of a

This paper posits a notion of the value of an individual’s human capital and the associated return on human capital. These concepts are examined using U.S. data on male earnings and financial asset returns. We find that (1) the value of human capital is far below the value implied by discounting earnings at the risk-free rate, (2) mean human capital returns exceed stock returns early in life an...

Integration of a Pharmacist into a Stroke Prevention Clinic Team

Stroke is the fourth leading cause of death in Canada, accounting for 14000 deaths annually. Between 40000 and 50000 strokes occur every year, 75% of which result in some type of impairment or disability. Stroke survivors have a 20% risk of another stroke within 2 years of the initial event, and 33% of all strokes are thought to be repeat episodes. The use of antiplatelet agents and the managem...

Evaluation of anticoagulant control in a pharmacist operated anticoagulant clinic.

AIMS To compare the quality of outpatient anticoagulant control before and after the transfer of dosing responsibility to designated trained pharmacists from rotating junior medical staff. METHODS All International Normalised Ratio (INR) values for an eight month period either side of the staff changeover were assessed for precision of therapeutic control according to described standards. All...